Andrew M. Farach, MD

Assistant Professor of Clinical Radiation Oncology, Academic Institute
Houston Methodist
Weill Cornell Medical College


Biography

Dr. Andrew Farach is an assistant professor in the Department of Radiation Oncology at Houston Methodist Hospital. His interest and special procedures are in breast cancer, brain cancer, gynecologic cancer, lung cancer, hepatobiliary cancer, gastrointestinal cancer, lymphoma, brachytherapy, stereotactic radiation/surgery. Dr. Farach earned his medical degree from Thomas Jefferson University, Jefferson Medical College in Philadelphia. He completed his internship at the University of Texas Health Science Center and his radiation oncology residency training at Baylor College of Medicine. He became Director of Brachytherapy in the Department of Radiation Oncology at Houston Methodist in 2018.  Dr. Farach is active in ASTRO (American Society of Therapeutic Radiology and Oncology), ACR (American College of Radiology), and the Texas Radiological Society (TRS). Dr. Farach has published peer-reviewed articles on topics such as SBRT outcomes in lung cancer, radiation and immunotherapy for breast cancer, and liver regeneration after SBRT. He plays an important role in cancer patient care, clinical research and the education of residents and students.

Publications

Approach to radiation therapy in the Jehovah's Witness patient: An overview
Jurica, JM, Messer, JA, Teh, BS, Butler, EB & Farach, AM 2020, , Reports of Practical Oncology and Radiotherapy, vol. 25, no. 6, pp. 856-859. https://doi.org/10.1016/j.rpor.2020.08.014

Radiation therapy in primary mediastinal large B-cell lymphoma treated with DA-R-EPOCH
Gentille, C, Anand, K, Dalwadi, S, Puri, A, Farach, A & Pingali, SR 2020, , Clinical Case Reports, vol. 8, no. 7, pp. 1153-1155. https://doi.org/10.1002/ccr3.2853

Brachytherapy
Dalwadi, SM, Farach, AM & Ludwig, MS 2020, , JAMA oncology, vol. 6, no. 4. https://doi.org/10.1001/jamaoncol.2019.5882

Controversies in the Management of Solid Tumor Bone Metastases
Farach, AM, Butler, EB & Teh, BS 2020, . in Medical Radiology. Medical Radiology, Springer, pp. 241-253. https://doi.org/10.1007/174_2019_217

Eye plaque brachytherapy versus enucleation for ocular melanoma: an analysis from the National Cancer Database
Messer, JA, Zuhour, RJ, Haque, W, Lewis, GD, Schefler, AC, Wong, A, Bernicker, EH, Chevez-Barrios, P, Michelle Quan, E, Farach, A, Butler, EB, Hatch, SS & Teh, BS 2020, , Journal of Contemporary Brachytherapy, vol. 12, no. 4, pp. 303-310. https://doi.org/10.5114/jcb.2020.98108

Co-registration of MR and FDG-PET imaging for stereotactic radiotherapy planning; case report in a previously irradiated brain metastasis with recurrent tumor and radiation necrosis
Scranton, RA, Sadrameli, S, Butler, EB, Farach, A, Wang, H-C, Teh, BS, Tremont-Lukats, IW, Fung, SH, Zanotti-Fregonara, P & Rostomily, RC 2019, , Practical Radiation Oncology. https://doi.org/10.1016/j.prro.2019.11.008

A matter of comprehensive informed consent: Short-term mortality rates with definitive treatment options in elderly stage i NSCLC
Dalwadi, SM, Savjani, RR, Bernicker, EH, Butler, EB, Teh, BS & Farach, AM 2019, American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 42, no. 11, pp. 851-855. https://doi.org/10.1097/COC.0000000000000606

The impact of molecular status on survival outcomes for invasive micropapillary carcinoma of the breast
Lewis, GD, Xing, Y, Haque, WM, Patel, T, Schwartz, MR, Chen, AC, Farach, AM, Hatch, SS, Butler, EB, Chang, JC & Teh, BS 2019, Breast Journal, vol. 25, no. 6, pp. 1171-1176. https://doi.org/10.1111/tbj.13432

Prognosis of lymphotropic invasive micropapillary breast carcinoma analyzed by using data from the National Cancer Database
Lewis, GD, Xing, Y, Haque, WM, Patel, T, Schwartz, M, Chen, A, Farach, AM, Hatch, SS, Butler, EB, Chang, JC & Teh, BS 2019, , Cancer Communications, vol. 39, no. 1, 60. https://doi.org/10.1186/s40880-019-0406-4

Socioeconomic Factors Associated with Lack of Treatment in Early Stage Non-Small Cell Lung Cancer
Dalwadi, SM, Zhang, J, Bernicker, EH, Butler, EB, Teh, BS & Farach, AM 2019, Cancer Investigation, vol. 37, no. 9, pp. 506-511. https://doi.org/10.1080/07357907.2019.1666136

Cardiovascular Toxicities of Radiation Therapy
Lewis, GD & Farach, AM 2019, Methodist DeBakey cardiovascular journal, vol. 15, no. 4, pp. 274-281. https://doi.org/10.14797/mdcj-15-4-274

The Role of Adjuvant Radiotherapy in the Treatment of Pleural Mesothelioma
Lewis, GD, Dalwadi, SM, Farach, AM, Butler, EB & Teh, BS 2019, , Annals of Surgical Oncology, vol. 26, no. 6, pp. 1879-1885. https://doi.org/10.1245/s10434-019-07235-9

Postmastectomy radiation therapy for triple negative, node-negative breast cancer
Haque, W, Verma, V, Farach, A, Brian Butler, E & Teh, BS 2019, , Radiotherapy and Oncology, vol. 132, pp. 48-54. https://doi.org/10.1016/j.radonc.2018.11.012

Disparities in the Treatment and Outcome of Stage I Non–Small-Cell Lung Cancer in the 21st Century
Dalwadi, SM, Lewis, GD, Bernicker, EH, Butler, EB, Teh, BS & Farach, AM 2019, , Clinical Lung Cancer, vol. 20, no. 3, pp. 194-200. https://doi.org/10.1016/j.cllc.2018.11.004

A rare presentation of choroidal metastasis from primary esophageal adenocarcinoma successfully treated with intensity-modulated radiation therapy
Date, RC, Adams, MK, Teh, BS, Schefler, AC, Musher, BL, Farach, AM & Weng, CY 2018, , American Journal of Ophthalmology Case Reports, vol. 11, pp. 19-22. https://doi.org/10.1016/j.ajoc.2018.04.021

Complete Local and Abscopal Responses from a Combination of Radiation and Nivolumab in Refractory Hodgkin's Lymphoma
Qin, Q, Nan, X, Miller, T, Fisher, R, Teh, B, Pandita, S, Farach, AM, Pingali, SR, Pandita, RK, Butler, EB, Pandita, TK & Iyer, SP 2018, , Radiation Research, vol. 190, no. 3, pp. 322-329. https://doi.org/10.1667/RR15048.1

Radiation Oncology in the Face of Natural Disaster: The Experience of Houston Methodist Hospital
Mireles, M, Pino, R, Teh, BS, Farach, A, Joseph, A & Butler, EB 2018, , International Journal of Radiation Oncology Biology Physics, vol. 100, no. 4, pp. 843-844. https://doi.org/10.1016/j.ijrobp.2017.12.002

Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer
Haque, W, Verma, V, Polamraju, P, Farach, A, Butler, EB & Teh, BS 2018, , Radiotherapy and Oncology, vol. 129, no. 2, pp. 264-269. https://doi.org/10.1016/j.radonc.2018.07.008

Renal cell carcinoma brain metastasis with pseudoprogression and radiation necrosis on nivolumab after previous treatment with stereotactic radiosurgery: An illustrative case report and review of the literature
Lewis, GD, Jonasch, E, Shah, AY, Fuller, GN, Farach, AM, Butler, EB & Teh, BS 2018, , Practical Radiation Oncology, vol. 8, no. 5, pp. e262-e265. https://doi.org/10.1016/j.prro.2018.03.003

Practice Patterns and Outcomes in Elderly Stage I Non–Small-cell Lung Cancer: A 2004 to 2012 SEER Analysis
Dalwadi, SM, Szeja, SS, Bernicker, EH, Butler, EB, Teh, BS & Farach, AM 2018, , Clinical Lung Cancer, vol. 19, no. 2, pp. e269-e276. https://doi.org/10.1016/j.cllc.2017.11.004